AVILA THERAPEUTICS INC — Form D

AVILA THERAPEUTICS INC of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-07-31. The offering totals $30.0M, of which $17.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Bruce BoothDirectorCambridge, MA
Daniel LynchDirectorGreenfield, IN
AMIR NASHATDirectorSan Diego, CA
Raj ParekhDirectorWaltham, MA
Vicki SatoDirectorSan Francisco, CA
HENRY SKINNERDirectorSAN DIEGO, CA
Daniel LynchExecutive OfficerGreenfield, IN
KATRINE BOSLEYDirectorCAMBRIDGE, MA
KATRINE BOSLEYExecutive OfficerCAMBRIDGE, MA
Michael F BighamDirectorLondon, X0
Michael F BighamExecutive OfficerLondon, X0
Roy R LobbDirectorWellesley, MA
Roy R LobbExecutive OfficerWellesley, MA
Henry R SkinnerDirectorWaltham, MA
Amir R NashatDirectorWaltham, MA
Raj R ParekhDirectorWaltham, MA
Bruce F BoothDirectorWaltham, MA
Vicki R SatoDirectorWaltham, MA
Daniel R LynchDirectorWaltham, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2010-07-06D/A$30.0M$22.5M
2009-05-14D$20.0M$5.0M

More